NEW YORK (AVAFIN) -- Financial institutions traded 30 block trades on shares of Idenix Pharmaceuticals. Further analysis
into the trading activity revealed that 611,906 shares were bought and
255,714 shares were sold. The bought/sold ratio for shares of IDIX is 2.39,
representing a positive net cash flow of $3,220,254 into the stock.
View all Block Trading Activities
A deeper look into options trading also reveals that traders hedged their positions with options
where 3,273 put and 4,690 call contracts exchanged hands leading to a 0.70
put/call ratio.
Shares of Idenix Pharmaceuticals closed at $9.00, down $1.25 (12.20%) in the last trading session.
Today's volume of 4M shares is greater than the average volume of 2M
shares. IDIX is trading below the 50 day moving average and higher
than the 200 day moving average. The stock's 52 week low is $2.82 and 52 week high is $15.25.
View Best Performing Stocks
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe.
